Stock listing
BDSX Stock Price, News, Filings & Events — Biodesix, Inc.
Selected listing: BDSX · NASDAQ · USD · US
This page tracks Biodesix, Inc.'s BDSX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BDSX:NASDAQ. BDSX:NASDAQ is the stock-level entry point for investors researching Biodesix, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biodesix, Inc. (ticker: BDSX) is a public company operating in the American market, with a market capitalization of approximately $227.8 million. The company focuses on developing diagnostic solutions for patients with lung diseases. Biodesix aims to improve patient outcomes through innovative testing and personalized medicine approaches.
- Ticker
- BDSX:NASDAQ
- Asset type
- Stock
- Market cap
- $281.0M
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- NASDAQ
- Currency
- USD
Biodesix, Inc. BDSX:NASDAQ stock context
This page tracks Biodesix, Inc.'s BDSX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BDSX:NASDAQ. BDSX:NASDAQ is the stock-level entry point for investors researching Biodesix, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biodesix, Inc. (ticker: BDSX) is a public company operating in the American market, with a market capitalization of approximately $227.8 million. The company focuses on developing diagnostic solutions for patients with lung diseases. Biodesix aims to improve patient outcomes through innovative testing and personalized medicine approaches.
Latest news from Biodesix, Inc.
Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference
August 4, 2026
Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026
July 22, 2026
Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Te...
May 11, 2026
Biodesix Announces First Quarter 2026 Results and Highlights
May 4, 2026
Biodesix Recognized as a Top Workplace for Third Consecutive Year
April 9, 2026
Biodesix, Inc. earnings calls
Biodesix, Inc. (BDSX) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
Biodesix, Inc. (BDSX) Q1 2026 Earnings Call
May 4, 2026 · Replay with transcript and chapters
Biodesix, Inc. (BDSX) Q4 2025 Earnings Call
February 26, 2026 · Replay with transcript and chapters
Biodesix, Inc. (BDSX) Q3 2025 Earnings Call
November 3, 2025 · Replay with transcript and chapters
Biodesix, Inc. (BDSX) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Biodesix, Inc. (BDSX) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Research Biodesix, Inc.
Biodesix, Inc. investor report
Review AI stock analysis and investor report context for BDSX:NASDAQ.
Biodesix, Inc. company profile
View the public company page for Biodesix, Inc. on 6ix.
Biodesix, Inc. news
Read company news and market updates connected to Biodesix, Inc..
Biodesix, Inc. investor events
Find investor webinars, events, and replay context for Biodesix, Inc..